- Previous Close
5.28 - Open
5.00 - Bid 5.19 x --
- Ask 5.21 x --
- Day's Range
5.03 - 5.28 - 52 Week Range
4.98 - 15.06 - Volume
217,304 - Avg. Volume
317,990 - Market Cap (intraday)
1.236B - Beta (5Y Monthly) 0.36
- PE Ratio (TTM)
8.97 - EPS (TTM)
0.58 - Earnings Date Oct 24, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 26, 2021
- 1y Target Est
--
ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. The Lab business unit provides laboratory furnishings, ventilation, climate/clean rooms, and laboratory equipment to pharmaceutical and life science research industries. It is also involved in design, construction, and installation of clean rooms. The Healthcare business unit manufactures and supplies medical equipment and consumables for healthcare and pharmaceuticals. In addition, it manufactures and sells surgical tables, as well as offers cables, connectors, and wires. Further, the company develops orthopedic implants, stents for foot and ankle surgery, equipment, and software for monitoring patients, as well as operates online pharmacy. Additionally, it sells consumable materials for ultrasound systems, and examines for urology and gynecology. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.
www.addvisegroup.seRecent News: ADDV-B.ST
View MorePerformance Overview: ADDV-B.ST
Trailing total returns as of 10/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ADDV-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ADDV-B.ST
View MoreValuation Measures
Market Cap
1.10B
Enterprise Value
2.50B
Trailing P/E
9.10
Forward P/E
6.52
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.63
Price/Book (mrq)
1.34
Enterprise Value/Revenue
1.54
Enterprise Value/EBITDA
6.95
Financial Highlights
Profitability and Income Statement
Profit Margin
7.00%
Return on Assets (ttm)
5.54%
Return on Equity (ttm)
15.43%
Revenue (ttm)
1.63B
Net Income Avi to Common (ttm)
114.4M
Diluted EPS (ttm)
0.58
Balance Sheet and Cash Flow
Total Cash (mrq)
400.6M
Total Debt/Equity (mrq)
229.95%
Levered Free Cash Flow (ttm)
54.2M